Prescription Ray‑Ban AI glasses
Meta and EssilorLuxottica are launching two prescription‑friendly Ray‑Ban AI glasses — Scriber and Blazer — in rectangular and rounded styles, distributed through opticians starting next week. The move targets the $223 billion global eyewear market and signals a push to make AI eyewear mainstream for prescription users. (thenextweb.com) (engadget.com)
US regulatory filings list the newcomers under model numbers RW7001 and RW7002, describe the devices as production‑ready units and show support for Wi‑Fi 6 (U‑NII‑4), signaling upgraded connectivity versus earlier Ray‑Ban models. (fccidlookup.com) The same filings record a portable charging case used in testing and specify the Blazer will be offered in both regular and large frame sizes. (theoutpost.ai) EssilorLuxottica’s Q4 2025 results state the company sold more than 7 million AI‑glasses in the full year, a figure CNBC described as a tripling of sales compared with 2023–24. (essilorluxottica.com) Bloomberg has reported Meta and EssilorLuxottica are discussing expanding annual production capacity to roughly 20–30 million Ray‑Ban smart‑glasses by the end of the year to keep pace with demand. (bloomberg.com) Separately, Bloomberg has reported the partners have clashed internally over pricing and market strategy as demand surged for the AI‑glass product line. (bloomberg.com) Industry coverage also flags a pending class‑action lawsuit alleging the glasses’ ecosystem enabled collection of sensitive video content by third‑party contractors, a legal risk that has accompanied the product’s rollout. (mediapost.com)
